Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
3 Months Ended
Feb. 29, 2016
Feb. 28, 2015
Revenues:    
Sales of health and beauty aid products - net $ 4,680,272 $ 6,952,857
Other income 4,172 4,659
Total Revenues 4,684,444 6,957,516
Costs and Expenses:    
Cost of sales 1,814,794 2,318,485
Selling, general and administrative expenses 2,073,975 3,089,758
Advertising, cooperative and promotional expenses 316,906 948,957
Research and development 8,201 40,524
Bad debt expense 810 6,971
Interest expense - related party 3,085 326,905
Interest expense 125,511 92,296
Total Costs and Expenses 4,343,282 6,823,896
Restructuring Costs 0 35,024
Total Costs and Expenses 4,343,282 6,858,920
Income before Provision for Income Taxes 341,162 98,596
Provision for Income taxes 132,222 40,988
Income from Continuing Operations 208,940 57,608
Discontinued Operations    
(Loss) from Discontinued Operations (9,096) 0
(Benefit from) income taxes (3,525) 0
(Loss) from Discontinued Operations (5,571) 0
Net Income $ 203,369 $ 57,608
Basic    
Continuing Operations (usd per share) $ 0.03 $ 0.01
Discontinued Operations (usd per share) 0.00 0.00
Income (usd per share) 0.03 0.01
Diluted    
Continuing Operations (usd per share) 0.03 0.01
Discontinued Operations (usd per share) 0.00 0.00
Income (usd per share) $ 0.03 $ 0.01
Weighted Average Common Shares Outstanding    
Basic (shares) 7,006,684 7,006,684
Diluted (shares) 7,047,765 7,155,242